A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：LANCET HIV ISSN： 2352-3018 出版频率： Monthly 出版社： ELSEVIER INC, 525 B STREET, STE 1900, SAN DIEGO, USA, CA, 92101-4495   出版社网址： http://www.journals.elsevier.com/the-lancet-hiv/ 期刊网址： http://www.thelancet.com/journals/lanhiv/issue/current 影响因子： 12.767 主题范畴： IMMUNOLOGY;    INFECTIOUS DISEASES 变更情况： Newly Added by 2015 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today. Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges. The Lancet HIV is a journal for a new era in the history of HIV/AIDS. The Lancet HIV builds on The Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV. Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research. Visit www.thelancet.com/hiv for more information. Instructions to Authors The Lancet HIV: Information for Authors The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. We will publish translational, epidemiological, clinical, operational, and implementation studies. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet HIV, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email TheLancetHIV@lancet.com). Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations) and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines. How to submit your paper Statements, permissions, and signatures Authors and contributors Declaration of interests Role of the funding source Role of medical writer or editor Patient and other consents Signatures Types of article and manuscript requirements Formatting guidelines Guidelines for supplementary material Disclosure of results before publication Online First publication How The Lancet HIV handles your paper Open access and funding What happens after publication? Download a PDF version of the full guidelines for authors of The Lancet HIV. LAST UPDATE: March, 2015 Instructions to Authors tlhiv-information-for-authors.pdf Editorial Board Editor Peter Hayward